Cancer Gene Therapy Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Gene Therapy Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Gene Therapy
Research in the area of cancer gene therapy reported from Cedars-Sinai Medical Center
May 7th, 2007
A new study, "Beta-2-microglobulin is an androgen-regulated secreted protein elevated in serum of patients with advanced prostate cancer," is now available. "A better understanding of secreted proteins may lead to the discovery of new biomarkers, which, along with prostate-specific antigen (PSA), may be useful in the diagnosis and treatment of prostate cancer patients. Conditioned medium was collected from LNCaP cells following stimulation with methyltrienolone (R1881), 17beta-estradiol (estradiol), or interleukin-6 and analyzed for differential protein expression with surface-enhanced laser desorption/ionization-time of flight mass spectrometry," investigators in the United States...
Source: Cancer Gene Therapy Week (2007-05-07)
|
